Stock Titan

Jaguar Health's Crofelemer Shows Benefit for Intestinal Failure (IF) in Third Rare Congenital Enteropathy Disorder

Jaguar Health (NASDAQ:JAGX) announced reduced parenteral support needs with investigational oral crofelemer in an infant with ...